Past Issues

See what you've been missing. Browse every issue of our free, daily briefing.

#1··12 stories

A blood test found 74% of deadly cancers — then its stock crashed 47%

A cancer screening test that actually works just failed the trial designed to prove it. Meanwhile, a CFO sold stock near rock bottom days before earnings, and the Supreme Court just yanked tariff power away from the president.

Get tomorrow's biotech intelligence before your competitors.

Join thousands of biotech professionals who start their day with our free, daily briefing.